Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 50Prostatic Neoplasms 44Multiple Myeloma 22Neoplasm Metastasis 17Osteoporosis 14Pain 11Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasms, Plasma Cell 5Lung Neoplasms 5Bone Diseases, Metabolic 5Fractures, Bone 4Bone Diseases 4Lymphoma 3Carcinoma, Renal Cell 3Bone Neoplasms 3Spinal Cord Compression 2Ovarian Neoplasms 2Osteosarcoma 2Neuroblastoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Renal Insufficiency 1Recurrence 1Pleural Effusion, Malignant 1

Interventions

Cyclophosphamide 67Dexamethasone 52Peripheral Blood Stem Cell Transplantation 37Lenalidomide 37Rituximab 35fludarabine phosphate 34Bortezomib 30Filgrastim 27Etoposide 27Cytarabine 25Carboplatin 25Busulfan 23Radiotherapy 22Melphalan 22Gemcitabine 22Cyclosporine 21pomalidomide 20fludarabine 20Whole-Body Irradiation 20Mycophenolic Acid 20Paclitaxel 19Methotrexate 18venetoclax 17Cisplatin 17pembrolizumab 16Calcium Dobesilate 16Bevacizumab 16Tacrolimus 14Antilymphocyte Serum 14Nivolumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Recurrence × Zoledronic Acid × Clear all
NCT00206388 2013-08-02

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

Baylor College of Medicine

Phase 1 Completed
21 enrolled
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡